Program Introduction Cancer pharmacology encompasses a wide range of therapeutic issues. In the early stages of new drug discovery, translational research has refined the identification of therapeutic targets for clinical relevance and applications. As our understanding of tumor molecular characteristics expands, it becomes more feasible to find existing drugs for drug repurposing or design new drugs that align with these specific characteristics for cancer treatment. Our training program intends to provide trainees with knowledge of cancer pharmacology, cancer biology, and required lab skills (cell culture, cell viability assays for drug screening, western blotting, flow cytometry analysis, immunofluorescence microscopy analysis) for the understanding of preclinical drug discovery for cancer therapy. Period of Apply: 2 months before the intended internship period (2026) Term: 2-6 months depending on availability (2026) Research Interests 1. Cancer Pharmacology 2. Cancer Biology 3. Signal transduction 4. Pre-clinical Drug Screening and Drug Discovery 5. Target-identification and mechanism-of-action studies of novel small molecules and herbal medicine We are interested in cell death, autophagy, epigenetic regulation, and DNA damage signaling pathways in cancerous cells. As tumor cells tend to escape from apoptosis by upregulating survival signaling or loss of tumor suppressor genes, induction of programmed cell death by novel small molecules or herbal medicine initiates proapoptotic response and leads to anticancer activity. In order to inhibit cancer cells proliferation and overcome drug resistance, currently we are focusing on antitumor effects and mechanism studies of dual inhibitors of targets for therapy in solid tumors. We are investigating how anticancer activity is altered, and the signal transduction paths that are activated by dual inhibitors. We are looking for students who are motivated, ambitious, and are interested in doing research with us. Faculty Profile B.S., School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan (2003) Ph.D., Department and Graduate Institute of Pharmacology , College of Medicine, National Taiwan University, Taipei, Taiwan (2012) Postdoctoral Training, College of Medicine, National Taiwan University, Taipei Taiwan (2012-2013) Postdoctoral Training, College of Pharmacy, Taipei Medical University, Taipei, Taiwan (2013-2014) Assistant Professor, PhD Program in Clinical Drug Development of Herbal Medicine, College of Pharmacy, Taipei Medical University, Taipei, Taiwan (2014-2018) Associate Professor, PhD Program in Clinical Drug Development of Herbal Medicine, College of Pharmacy, Taipei Medical University, Taipei, Taiwan (2018-2021) Associate Professor, School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan (2021-2023) Professor, School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan (2023-Present) Joint-Appointment Professor, Graduate Institute of Pharmacognosy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan (2023-Present) Joint-Appointment Professor, PhD Program in Clinical Drug Development of Herbal Medicine, College of Pharmacy, Taipei Medical University, Taipei, Taiwan (2023-Present) Joint-Appointment Professor, Master Program in Clinical Genomics and Proteomics, College of Pharmacy, Taipei Medical University, Taipei, Taiwan (2023-Present) Joint-Appointment Professor, PhD Program in Drug Discovery and Development Industry, College of Pharmacy, Taipei Medical University, Taipei, Taiwan (2023-Present) Member, TMU Research Center of Drug Discovery Member, TMU Research Center of Thoracic Medicine The Chair of the Department of Pharmaceutical Sciences, School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan (2024/1/1-2025/7/31) The Director of School of Pharmacy, Taipei Medical University, Taipei, Taiwan (2025/8/1~present)